Next Article in Journal
Metal-Free Carbon-Based Materials: Promising Electrocatalysts for Oxygen Reduction Reaction in Microbial Fuel Cells
Next Article in Special Issue
Pre-Exposure Gene Expression in Baboons with and without Pancytopenia after Radiation Exposure
Previous Article in Journal
Novel Structural Approaches to Study GPCR Regulation
Previous Article in Special Issue
Low Concentration of Exogenous Carbon Monoxide Modulates Radiation-Induced Bystander Effect in Mammalian Cell Cluster Model
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle

Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection

Center for Nanomedicine & Drug Delivery, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125, USA
Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Terrence Piva
Int. J. Mol. Sci. 2017, 18(1), 28;
Received: 28 September 2016 / Revised: 2 December 2016 / Accepted: 14 December 2016 / Published: 24 December 2016
(This article belongs to the Collection Radiation Toxicity in Cells)
PDF [5869 KB, uploaded 24 December 2016]


The purpose of this study was two-fold: (1) to formulate γ-tocotrienol (GT3) in a nanoemulsion formulation as a prophylactic orally administered radioprotective agent; and (2) to optimize the storage conditions to preserve the structural integrity of both the formulation and the compound. γ-tocotrienol was incorporated into a nanoemulsion and lyophilized with lactose. Ultra performance liquid chromatography–mass spectroscopy (UPLC–MS) was used to monitor the chemical stability of GT3 over time, the particle size and ζ potential, and scanning electron microscopy (SEM) were used to study the physical stability of the nanoemulsion. Radioprotective and toxicity studies were performed in mice. The liquid formulation exhibited GT3 degradation at all storage temperatures. Lyophilization, in the presence of lactose, significantly reduced GT3 degradation. Both the liquid and lyophilized nanoemulsions had stable particle size and ζ potential when stored at 4 °C. Toxicity studies of the nanoemulsion resulted in no observable toxicity in mice at an oral dose of 600 mg/kg GT3. The nano-formulated GT3 (300 mg/kg) demonstrated enhanced survival efficacy compared to GT3 alone (200 and 400 mg/kg) in CD2F1 mice exposed to total body gamma radiation. The optimal long-term storage of formulated GT3 is as a powder at −20 °C to preserve drug and formulation integrity. Formulation of GT3 as a nanoemulsion for oral delivery as a prophylactic radioprotectant shows promise and warrants further investigation. View Full-Text
Keywords: γ-tocotrienol; GT3; nanoemulsion; dry emulsion; radioprotection; lyophilization γ-tocotrienol; GT3; nanoemulsion; dry emulsion; radioprotection; lyophilization

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Ledet, G.A.; Biswas, S.; Kumar, V.P.; Graves, R.A.; Mitchner, D.M.; Parker, T.M.; Bostanian, L.A.; Ghosh, S.P.; Mandal, T.K. Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection. Int. J. Mol. Sci. 2017, 18, 28.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top